Ultrasound-Guided Posterior Iliac Crest Aspiration A Case Series

Main Article Content

Nicholas Ott
Barry Garcia

Keywords

Bone marrow aspirate, Posterior iliac crest, Ultrasound guided bone marrow aspiration

Abstract

Background: Bone Marrow Aspirate (BMA) contains growth factors and signaling entities essential for local cellular repair. BMA and concentrated BMA injections (BMC) are used for orthopedic procedures, such as in treating cartilaginous and bony defects. Several techniques exist for harvesting BMA. A technique termed ultrasound-guided posterior iliac crest aspiration (UPICA) is of special interest. This case series was
undertaken to determine if practitioners can effectively perform the UPICA technique in a clinical setting.


Methods: In accordance with the UPICA technique, ultrasound guidance was used to localize the posterior iliac crest. Following local anesthesia, aspiration was performed using 10 mL syringes at multiple depths. The periosteum was entered once. A needle was advanced 0.5 cm with each new depth. At each penetration level, 10 mL was drawn before rotating 90 degrees and aspirating an additional 10 mL. Following aspiration at various depths, approximately 60 mL of BMA was obtained. The inclusion criteria for this study were patients with diagnosed glenohumeral osteoarthritis, knee osteoarthritis, hip osteoarthritis, or rotator cuff tears whose condition had failed to improve with conservative care. The UPICA technique was performed in each case by the senior author (BG).


Results: For the 10 cases, the average patient age was 72 (SD 7.6; range 58–81) years old. The sample included 8 males and 2 females. The mean total nucleated cell count (TNCC)/mL BMA was 9.7E+06 (SD  2.9E+06), while the TNCC/mL bone marrow concentrate (BMC) was 43.9E+06 (SD 29.5E+06), a 4.3 (SD 2.3)-fold increase in concentration. The mean cell colony forming units-fibroblasts (CFU-f)/mL BMA was 520 (SD 155) with a mean CFU-f/mL BMC of 4899 (SD 2887) resulting in a 9.6 (SD 4.6)-fold increase in concentration. The viability for the BMA was 97.5 (SD 2.3) %, and the BMC was 94.9 (SD 4.55) %.


Conclusions: Utilizing the UPICA technique, similar yields for the BMC CFU-f/mL counts were obtained to those reported previously by other clinicians. Additionally, the results demonstrated the ability of the bone marrow concentration system to successfully concentrate the BMA. Based on these findings, the research team endorses the UPICA technique as a viable method for bone marrow aspiration.

Abstract 276 | PDF Downloads 192

References


1. Gianakos AL, Sun L, Patel JN, et al. Clinical application of concentrated bone marrow aspirate in orthopaedics: A systematic review. World J Orthop. 2017;8(6):491-506. https://doi:10.5312/wjo.v8.i6.491
2. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129(3):163-73. https://doi: 10.1016/j.mad.2007.12.002
3. Oliver K, Awan T, Bayes M. Single- Versus Multiple-Site Harvesting Techniques for Bone Marrow Concentrate: Evaluation of Aspirate Quality and Pain. Orthop J Sports Med. 2017;5(8):2325967117724398. https://doi:10.1177/2325967117724398
4. Centeno CJ, Al-Sayegh H, Bashir J, Goodyear S, Freeman MD. A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis. BMC Musculoskelet Disord. 2015;16:258. https://doi:10.1186/s12891-015-0714-z
5. Vega A, Martín-Ferrero MA, Del Canto F, et al. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015;99(8):1681-1690. https://doi:10.1097/TP.0000000000000678
6. Hyer CF, Berlet GC, Bussewitz BW, et al. Quantitative assessment of the yield of osteoblastic connective tissue progenitors in bone marrow aspirate from the iliac crest, tibia, and calcaneus. J Bone Joint Surg Am. 2013;95(14):1312-1316. https://doi: 10.2106/JBJS.L.01529
7. Friedlis MF, Centeno CJ. Performing a Better Bone Marrow Aspiration. Phys Med Rehabil Clin N Am. 2016;27(4):919-939. https://doi: 10.1016/j.pmr.2016.06.009
8. Buford, D. (July 26-28, 2018). Musculoskeletal Ultrasound and Orthobiologics Course.
9. Ulasli AM, Ozcakar L, Murrel WD. Ultrasound imaging and guidance in the management of knee osteoarthritis in regenerative medicine field. J Clin Orthop Trauma. 2019 Jan-Feb;10(1):24-31. doi: 10.1016/j.jcot.2018.11.015. Epub 2018 Nov 30. PMID: 30705527; PMCID: PMC6349666
10. Hernigou J, Picard L, Alves A, et al. Understanding bone safety zones during bone marrow aspiration from the iliac crest: the sector rule. International Orthopaedics (SICOT). 2014;38:2377–2384. https://doi.org/10.1007/s00264-014-2343-9
11. Hernigou P, Flouzat Lachaniette CH, Delambre J, et al. Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study. Int Orthop. 2014;38(9):1811-1818. https://doi: 10.1007/s00264-014-2391-1
12. Witt PL, McGrain P. Comparing two sample means t tests. Phys Ther. 1985 Nov;65(11):1730-3. doi: 10.1093/ptj/65.11.1730. PMID: 4059334.
13. Fennema EM, Renard AJ, Leusink A, et al. The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells. Acta orthop. 2009;80(5):618-621. https://doi: 10.3109/17453670903278241
14. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am. 1997;79(11):1699-709. doi: 10.2106/00004623-199711000-00012. Erratum in: J Bone Joint Surg Am. 1998;80(2):302.
15. Bertram H, Mayer H, Schliephake H. Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone. Clin Oral Implants Res. 2005;16(5):524-531. https://doi:10.1111/j.1600-0501.2005.01142.x